Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
143.68
-0.68 (-0.47%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $4.16 billion as of September 12, 2025. Its market cap has decreased by -26.98% in one year.
Market Cap
4.16B
Enterprise Value
3.35B
1-Year Change
-26.98%
Ranking
Category
Stock Price
$143.68
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $102.60M to $4.16B, an increase of 3,952.98%. That is a compound annual growth rate of 59.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 4.16B | -7.70% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 17.08% |
| Dec 31, 2021 | 1.74B | 47.34% |
| Dec 31, 2020 | 1.18B | 23.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novartis AG | 247.58B |
| Novo Nordisk | 242.99B |
| Abbott Laboratories | 232.75B |